Numerous studies conducted by researchers at Dana-Farber Cancer Institute report progress for cancers including head and neck cancer, metastatic breast cancer and lung cancer.

IBI3014 is a bispecific ADC targeting TROP2 and PD-L1. Its dual mechanism integrates TROP2-directed tumor killing with PD-L1 ...

Nona Biosciences, a global biotechnology company providing integrated solutions from 'Idea to IND' (I to ITM), today ...

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, ...

Immigration officials deported three US citizen children — ages 2, 4, and 7 — along with their mothers late last week, ...

Ahmedabad: A global research comprising of 8,438 patients suffering from colorectal cancer caused by Lynch Syndrome has ...

Combining Lynparza (olaparib) and Keytruda (pembrolizumab) showed antitumor activity in multiple cancer types, particularly those with BRCA1/2 ...

A multiple sclerosis patient who received a stem cell transplant in Denver is now doing well and hopes to spread awareness ...

Researchers at Mass General Brigham discovered that interactions between immune cells and brain cells play a key role in ...

Dostarlimab effectively eliminates the need for surgery in patients with advanced mismatch repair-deficient (dMMR) tumors, ...

Historically, the vast majority of pharmaceutical drugs have been meticulously designed down to the atomic level.

Researchers have developed an AI system that predicts brain tumor recurrence in children using sequential MRI scans. By ...